Drug General Information
Drug ID
D05UUA
Former ID
DNC006918
Drug Name
(+/-)-6-(2-chlorophenyl)cyclohex-3-enamine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528488]
Structure
Download
2D MOL

3D MOL

Formula
C12H14ClN
Canonical SMILES
C1C=CCC(C1C2=CC=CC=C2Cl)N
InChI
1S/C12H14ClN/c13-11-7-3-1-5-9(11)10-6-2-4-8-12(10)14/h1-5,7,10,12H,6,8,14H2/t10-,12+/m1/s1
InChIKey
UAUINBMLUPAKPF-PWSUYJOCSA-N
PubChem Compound ID
Target and Pathway
Target(s) Dipeptidyl peptidase IV Target Info Inhibitor [528488]
KEGG Pathway Protein digestion and absorption
NetPath Pathway IL2 Signaling Pathway
TGF_beta_Receptor Signaling Pathway
References
Ref 528488J Med Chem. 2006 Nov 2;49(22):6439-42.Discovery of ((4R,5S)-5-amino-4-(2,4,5- trifluorophenyl)cyclohex-1-enyl)-(3- (trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanone (ABT-341), a highly potent, selective, orally efficacious, and safe dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.
Ref 528488J Med Chem. 2006 Nov 2;49(22):6439-42.Discovery of ((4R,5S)-5-amino-4-(2,4,5- trifluorophenyl)cyclohex-1-enyl)-(3- (trifluoromethyl)-5,6-dihydro- [1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)methanone (ABT-341), a highly potent, selective, orally efficacious, and safe dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.